Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Psychiatr Res ; 79: 116-124, 2016 08.
Article in English | MEDLINE | ID: mdl-27218817

ABSTRACT

This is the first longitudinal twin study examining genetic and environmental contributions to the association between liability to bipolar disorder (BD) and changes over time in global brain volumes, and global and regional measures of cortical surface area, cortical thickness and cortical volume. A total of 50 twins from pairs discordant or concordant for BD (monozygotic: 8 discordant and 3 concordant pairs, and 1 patient and 3 co-twins from incomplete pairs; dizygotic: 6 discordant and 2 concordant pairs, and 1 patient and 7 co-twins from incomplete pairs) underwent magnetic resonance imaging twice. In addition, 57 twins from healthy twin pairs (15 monozygotic and 10 dizygotic pairs, and 4 monozygotic and 3 dizygotic subjects from incomplete pairs) were also scanned twice. Mean follow-up duration for all twins was 7.5 years (standard deviation: 1.5 years). Data were analyzed using structural equation modeling software OpenMx. The liability to BD was not associated with global or regional structural brain changes over time. Although we observed a subtle increase in cerebral white matter in BD patients, this effect disappeared after correction for multiple comparisons. Heritability of brain changes over time was generally low to moderate. Structural brain changes appear to follow similar trajectories in BD patients and healthy controls. Existing brain abnormalities in BD do not appear to progressively change over time, but this requires additional confirmation. Further study with large cohorts is recommended to assess genetic and environmental influences on structural brain abnormalities in BD, while taking into account the influence of lithium on the brain.


Subject(s)
Bipolar Disorder/diagnostic imaging , Bipolar Disorder/epidemiology , Brain/diagnostic imaging , Gene-Environment Interaction , Adult , Antimanic Agents/therapeutic use , Bipolar Disorder/drug therapy , Bipolar Disorder/genetics , Brain/drug effects , Diseases in Twins , Female , Follow-Up Studies , Humans , Lithium Compounds/therapeutic use , Longitudinal Studies , Magnetic Resonance Imaging , Male , Organ Size , Socioeconomic Factors , Twins, Dizygotic , Twins, Monozygotic
2.
Psychol Med ; 45(1): 193-204, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25065711

ABSTRACT

BACKGROUND: The risk of developing bipolar disorder (BD) has been linked to structural brain abnormalities. The degree to which genes and environment influence the association of BD with cortical surface area remains to be elucidated. In this twin study, genetic and environmental contributions to the association between liability to develop BD and surface area, thickness and volume of the cortex were examined. METHOD: The study cohort included 44 affected monozygotic (nine concordant, 12 discordant) and dizygotic (four concordant, 19 discordant) twin pairs, and seven twins from incomplete discordant monozygotic and dizygotic discordant twin pairs. In addition, 37 monozygotic and 24 dizygotic healthy control twin pairs, and six twins from incomplete monozygotic and dizygotic control pairs were included. RESULTS: Genetic liability to develop BD was associated with a larger cortical surface in limbic and parietal regions, and a thicker cortex in central and parietal regions. Environmental factors related to BD were associated with larger medial frontal, parietal and limbic, and smaller orbitofrontal surfaces. Furthermore, thinner frontal, limbic and occipital cortex, and larger frontal and parietal, and smaller orbitofrontal volumes were also associated with environmental factors related to BD. CONCLUSIONS: Our results suggest that unique environmental factors play a prominent role in driving the associations between liability to develop BD and cortical measures, particularly those involving cortical thickness. Further evaluation of their influence on the surface and thickness of the cortical mantle is recommended. In addition, cortical volume appeared to be primarily dependent on surface and not thickness.


Subject(s)
Bipolar Disorder/genetics , Bipolar Disorder/physiopathology , Cerebellar Cortex/physiopathology , Gene-Environment Interaction , Adolescent , Adult , Algorithms , Cohort Studies , Female , Genetic Predisposition to Disease/genetics , Humans , Interviews as Topic , Limbic System/physiopathology , Linear Models , Male , Middle Aged , Neuroimaging , Twins, Dizygotic/genetics , Twins, Monozygotic/genetics , Young Adult
3.
Eur Neuropsychopharmacol ; 24(12): 1885-95, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25451699

ABSTRACT

Palmar and finger dermatoglyphics are formed between the 10th and the 17th weeks of gestation and their morphology can be influenced by genetic or environmental factors, interfering with normal intrauterine development. As both the skin and the brain develop from the same embryonal ectoderm, dermatoglyphic alterations may be informative for early abnormal neurodevelopmental processes in the brain. We investigated whether dermatoglyphic alterations are related to structural brain abnormalities in bipolar disorder and to what extent they are of a genetic and of an environmental origin. Dermatoglyphics and volumetric data from structural MRI were obtained in 53 twin pairs concordant or discordant for bipolar disorder and 51 healthy matched control twin pairs. Structural equation modeling was used. Bipolar disorder was significantly positively associated with palmar a-b ridge count (ABRC), indicating higher ABRC in bipolar patients (rph=.17 (CI .04-.30)). Common genes appear to be involved because the genetic correlation with ABRC was significant (rph-A=.21 (CI .05-.36). Irrespective of disease, ABRC showed a genetically mediated association with brain volume, indicated by a significant genetic correlation rph-A of respectively -.36 (CI -.52 to -.22) for total brain, -.34 (CI -.51 to -.16) total cortical volume, -.27 (CI -.43 to -.08) cortical gray matter and -.23 (CI -.41 to -.04) cortical white matter. In conclusion, a genetically determined abnormal development of the foetal ectoderm between the 10th and 15th week of gestation appears related to smaller brain volumes in (subjects at risk for) bipolar disorder.


Subject(s)
Bipolar Disorder/genetics , Bipolar Disorder/pathology , Brain/pathology , Dermatoglyphics , Twins, Dizygotic/genetics , Twins, Monozygotic/genetics , Adolescent , Adult , Bipolar Disorder/psychology , Case-Control Studies , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neuroimaging , Organ Size , Twins, Dizygotic/psychology , Twins, Monozygotic/psychology , Young Adult
4.
J Affect Disord ; 136(3): 294-303, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22166398

ABSTRACT

BACKGROUND: Although the genetic risk to develop bipolar disorder is present from conception, the first frank symptoms of the illness generally become evident in late adolescence or early adulthood. However, except for pediatric bipolar disorder (PBD), it is still unclear when the first signs of the illness in adults become apparent and whether these are related to the genetic risk to develop bipolar disorder. This study examined whether underperformance at school precedes the onset of the illness and is a genetically related risk marker for developing bipolar disorder. METHODS: Information on school performance was obtained using objective archival data from 53 bipolar twin pairs (24 monozygotic (MZ), 29 dizygotic (DZ)) and 42 healthy matched control twin pairs (23 MZ, 19 DZ). RESULTS: Affected twin pairs completed significantly fewer years of education than did control twin pairs with no difference between bipolar patients and their non-bipolar cotwins. The underperformance at school in the affected twin pairs occurred in early adolescence at a significantly younger age than the control twin pairs and preceded the onset of the first frank episode of bipolar disorder by thirteen years. Median age at onset of underperformance was not different in the patients and their non-bipolar cotwins. The association between liability of bipolar disease and age of first underperformance was significant and could be explained by genetic factors. LIMITATIONS: The sample is not a population based twin sample. CONCLUSION: Underperformance at school during early adolescence may be a genetic marker for the vulnerability to develop bipolar disorder.


Subject(s)
Bipolar Disorder/genetics , Diseases in Twins/genetics , Educational Status , Adult , Female , Genetic Markers , Humans , Male , Middle Aged , Risk Factors , Twins, Dizygotic/genetics , Twins, Monozygotic/genetics
5.
Am J Psychiatry ; 155(12): 1784-6, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9842796

ABSTRACT

OBJECTIVE: The authors' goal was to compare the thalamic, total brain, and intracranial volumes of patients with schizophrenia, their healthy siblings, and normal comparison subjects. METHOD: Magnetic resonance imaging (MRI) brain scans were obtained for 32 same-sex siblings who were discordant for schizophrenia and 32 matched normal comparison subjects. RESULTS: Mean total thalamic volume, corrected for total brain volume, was significantly different among affected siblings, unaffected siblings, and comparison subjects. Thalamic volume was smallest in the patients; thalamic volume in their siblings was smaller than that of comparison subjects but larger than that of the patients with schizophrenia. CONCLUSIONS: These results suggest that healthy siblings of patients with schizophrenia partially share the thalamic abnormalities of their affected relatives.


Subject(s)
Family , Schizophrenia/genetics , Thalamus/anatomy & histology , Brain/anatomy & histology , Female , Genetic Predisposition to Disease , Humans , Magnetic Resonance Imaging , Male
6.
J Clin Oncol ; 14(3): 984-96, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8622050

ABSTRACT

PURPOSE: Here we report the results of a randomized study undertaken to test the efficacy of a supplementary, telephone-based nursing intervention in increasing patients' awareness and understanding of the clinical trials in which they are asked to participate. METHODS: During a 12-month period, 180 cancer patients who were approached to participate in a phase II or III clinical trial were randomized to undergo either of the following: (1) standard informed consent procedures based on verbal explanations from the treating physician plus written information (controls); or (2) standard informed consent procedures plus a supplementary, telephone-based contact with an oncology nurse (intervention). For purposes of evaluation, face-to-face interviews were conducted with all patients approximately 1 week after the informed consent process had been completed. RESULTS: The two groups were comparable with regard to sociodemographic and clinical variables. Both groups had a high level of awareness of the diagnosis and of the nature and objectives of the proposed treatments. The intervention group was significantly (P < .01) better informed about the following: (1) the risks and side effects of treatment; (2) the clinical trial context of the treatment; (3) the objectives of the clinical trial; (4) where relevant, the use of randomization in allocating treatment; (5) the availability of alternative treatments; (6) the voluntary nature of participation; and (7) the right to withdraw from the clinical trial. The intervention did not have any significant effect on patients' anxiety levels or on rates of clinical trial participation. Patients reported high levels of satisfaction with the intervention. CONCLUSION: The use of a supplementary, telephone-based nursing intervention is a feasible and effective means to increase cancer patients' awareness and understanding of the salient issues that surround the clinical trials in which they are asked to participate.


Subject(s)
Clinical Trials, Phase II as Topic/nursing , Clinical Trials, Phase III as Topic/nursing , Informed Consent , Nursing Assessment , Patient Acceptance of Health Care , Patient Selection , Telephone , Adult , Aged , Bias , Clinical Trials, Phase II as Topic/adverse effects , Clinical Trials, Phase II as Topic/psychology , Clinical Trials, Phase III as Topic/adverse effects , Clinical Trials, Phase III as Topic/psychology , Female , Humans , Male , Middle Aged , Patient Advocacy , Physician-Patient Relations , Referral and Consultation/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL
...